Status:
COMPLETED
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Non-Hodgkin Lymphoma
Acute Lymphoblastic Leukemia, Mature B-Cell
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE2
Brief Summary
This is a pilot study to demonstrate that the modified LMB-89 treatment regimen for children with newly diagnosed small noncleaved cell NHL, large cell NHL (B-cell), and B-cell acute lymphoblastic leu...
Detailed Description
Group A: Resected Stage I and resected abdominal Stage II Subjects will receive two courses (3 weeks apart) of COPAD as follows: Cyclophosphamide (CTX) 500 mg/m2/day (divided q12 hrs) IV day 1, 2, 3...
Eligibility Criteria
Inclusion
- Subject must be previously untreated, except for steroids.
- Subject must be less than or equal to 18 years of age.
- Subject must have a histologic diagnosis of small noncleaved cell (SNCC) NHL or large cell NHL (B-cell), or B-cell acute lymphocytic leukemia.
Exclusion
- Previously treated disease
Key Trial Info
Start Date :
November 1 1994
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00187161
Start Date
November 1 1994
End Date
January 1 2007
Last Update
June 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105